Sandbox PgpWWC

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
==P-glycoprotein==
==P-glycoprotein==
<StructureSection load='4m1m' size='340' side='right' caption='P-glycoprotein: Both domains at 3.5 Å resolution ' scene=''>
<StructureSection load='4m1m' size='340' side='right' caption='P-glycoprotein: Both domains at 3.5 Å resolution ' scene=''>
-
'''P-glycoprotein (P-gp, ABCB1)''' is an ATP casette transporter that hydrolyses ATP for conformational changes after a variety of substrates are transported. It is one of the membrane proteins responsible for the multi drug resistance (MDR) in cancer treatment, as well as various other drug therapies (Aller et. al 2009; He and Liu 2002). P-gp can be found in tumor cells, as well as in the liver, kidney, adrenal gland, intestine, blood-brain barrier (BBB), placenta, blood-testis barrier, and blood-ovarian barriers. An effective MDR transport protein, the high amount of active Pgp substrates stems from the polyspecificity for hydrophobic and aromatic compounds (Marchetti, Mazzanti, Beijnen, & Schellens 2007).
+
'''P-glycoprotein (P-gp, ABCB1)''' is an ATP casette transporter that hydrolyses ATP for conformational changes after a variety of substrates are transported. It is one of the membrane proteins responsible for the multi drug resistance (MDR) in cancer treatment, as well as various other drug therapies <ref>Aller, S., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., . . . Chang, G. (2009). Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding. Science, 323(5922), 1718-1722. Retrieved April 4, 2015, from National Institutes of Health</ref><ref>He, L., & Liu, G. Q. (2002). Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. Acta Pharmacologica Sinica, 23(7), 591-596</ref>. P-gp can be found in tumor cells, as well as in the liver, kidney, adrenal gland, intestine, blood-brain barrier (BBB), placenta, blood-testis barrier, and blood-ovarian barriers. An effective MDR transport protein, the high amount of active Pgp substrates stems from the polyspecificity for hydrophobic and aromatic compounds (Marchetti, Mazzanti, Beijnen, & Schellens 2007).
{{Template:ColorKey_Hydrophobic}}, {{Template:ColorKey_Polar}}
{{Template:ColorKey_Hydrophobic}}, {{Template:ColorKey_Polar}}
<scene name='69/699852/Hydrophobic_residues/4'>TextToBeDisplayed</scene>
<scene name='69/699852/Hydrophobic_residues/4'>TextToBeDisplayed</scene>

Revision as of 16:01, 9 April 2015

P-glycoprotein

P-glycoprotein: Both domains at 3.5 Å resolution

Drag the structure with the mouse to rotate

References

  1. Aller, S., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., . . . Chang, G. (2009). Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding. Science, 323(5922), 1718-1722. Retrieved April 4, 2015, from National Institutes of Health
  2. He, L., & Liu, G. Q. (2002). Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. Acta Pharmacologica Sinica, 23(7), 591-596
Personal tools